Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000712384 | SCV000842861 | uncertain significance | not provided | 2018-07-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001087485 | SCV001020377 | likely benign | Nemaline myopathy 2 | 2024-10-15 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000712384 | SCV003810325 | uncertain significance | not provided | 2020-12-11 | criteria provided, single submitter | clinical testing | |
Genome |
RCV001087485 | SCV001423190 | not provided | Nemaline myopathy 2 | no assertion provided | phenotyping only | Variant interpretted as Uncertain significance and reported on 07-31-2017 by Lab or GTR ID 165021. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. | |
Natera, |
RCV001087485 | SCV001454687 | uncertain significance | Nemaline myopathy 2 | 2020-01-24 | no assertion criteria provided | clinical testing |